Crossmark

Translational PK-PD/TD modeling of antitumor effects and peripheral neuropathy in gemcitabine and nab-paclitaxel chemotherapy from xenograft mice to patients for optimal dose and schedule

Crossref DOI link: https://doi.org/10.1007/s00280-023-04625-5

Published Online: 2023-12-20

Published Print: 2024-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kobuchi, Shinji

Morita, Atsuko

Jonan, Shizuka

Amagase, Kikuko

Ito, Yukako https://orcid.org/0000-0002-6608-4935
Funding

Funding for this research was provided by:

Japan Society for the Promotion of Science (21K06679)
License Information

Text and Data Mining valid from 2023-12-20

Version of Record valid from 2023-12-20
More Information

Article History

Received: 5 April 2023

Accepted: 24 November 2023

First Online: 20 December 2023

Declarations

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below